Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.992
+0.011 (1.16%)
At close: Dec 5, 2025, 4:00 PM EST
0.975
-0.017 (-1.71%)
After-hours: Dec 5, 2025, 6:58 PM EST
Oncolytics Biotech Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Oncolytics Biotech stock have an average target of 6.00, with a low estimate of 3.00 and a high estimate of 10. The average target predicts an increase of 504.78% from the current stock price of 0.99.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Oncolytics Biotech stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +907.96% | Nov 17, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +605.57% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +403.98% | May 21, 2025 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 16, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +202.39% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.02M
EPS This Year
-0.32
from -0.41
EPS Next Year
-0.35
from -0.32
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 6.3M | ||||
| Avg | n/a | 2.0M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.28 | -0.29 | |
| Avg | -0.32 | -0.35 | |
| Low | -0.38 | -0.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.